CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Columbus, Ohio, United States and 43 other locations
This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...
Phase 3
Columbus, Ohio, United States and 167 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Columbus, Ohio, United States and 123 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Columbus, Ohio, United States and 25 other locations
This phase II trial studies how well nivolumab and temozolomide work in treating patients with small-cell lung cancer that has come...
Phase 2
Columbus, Ohio, United States and 1 other location
PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...
Phase 2
Columbus, Ohio, United States of America and 24 other locations
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung ...
Phase 2
Columbus, Ohio, United States and 4 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Columbus, Ohio, United States and 157 other locations
This study will consist of a Phase 1b and Phase 2 portion. The Phase 1b portion will enroll first followed by the Phase 2 portion. Each cycle of trea...
Phase 1, Phase 2
Columbus, Ohio, United States and 1 other location
therapy in patients with stage IV non-squamous non-small cell lung cancer (NSCLC) without progressive disease (PD), as confirmed on...
Phase 1, Phase 2
Columbus, Ohio, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal